Latest / Salt Lake City News Today | 2 Min News | The Daily News Now!
GLP-1 Drugs: Access Over Adoption | Salt Lake City News
Gallup’s latest data reveals a fourfold surge in GLP-1 drug use over two years, yet only 11% of users are on them for weight loss—despite 70% of U.S. adults being overweight or obese. Cost and insurance coverage remain the biggest barriers, with most users relying on pricey brand-name versions and no generics available. Compounded pharmacy versions lack FDA oversight, while drugs like Ozempic and Wegovy, Zepbound, and Mounjaro are essentially the same compound with different approvals. Though injectables still edge out oral options in effectiveness, experts stress these meds aren’t magic…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.